Lorrain Daniel S.
5 of 13 shown
The 5 most recent of 13 visible filings, newest first.
- Contineum Therapeutics, Inc. Chief scientific officer25 sharesOption exercise
- Contineum Therapeutics, Inc. Chief scientific officer$400Open-market sale
- Contineum Therapeutics, Inc. Chief scientific officer$25Option exercise
- Contineum Therapeutics, Inc. Chief scientific officer1,015 sharesOption exercise
- Contineum Therapeutics, Inc. Chief scientific officer$16,240Open-market sale